A pioneer experience in Malaysia on In-house Radio-labelling of 131I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose 131I-rituximab-BEAM conditioning autologous transplant-Reference-Cited by-同舟云学术

A pioneer experience in Malaysia on In-house Radio-labelling of 131I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose 131I-rituximab-BEAM conditioning autologous transplant

Published:2016-10 Issue: Volume:116 Page:13-21
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Kuan Jew Win,Law Chiong Soon,Wong Xiang Qi,Ko Ching Tiong,Awang Zool Hilmi,Chew Lee Ping,Chang Kian Meng

Publisher

Elsevier BV

Subject

Radiation

Reference59 articles.

1. Outcomes after (90)Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis;Auger-Quittet;Cancer Med.,2014

2. High-dose myeloablative radioimmunotherapy of mantle cell Non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study;Behr;Cancer,2002

3. Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade Non-Hodgkin lymphoma;Bethge;Bone Marrow Transpl.,2012

4. Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in (131)I-anti-CD20 rituximab radioimmunotherapy of Non-Hodgkin’s lymphoma;Boucek;Eur. J. Nucl. Med. Mol. Imaging,2005

5. Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission;Buchegger;J. Nucl. Med.,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation;Majalah Kedokteran Bandung;2019-06